Okomera secured €1.5 Million Grant
Okomera secured €1.5 Million Grant to Develop Microfluidics & AI Powered CRISPR Editing Platform for Target Validation !
Bpifrance is funding their novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM - Centre de Recherche en Cancérologie de Marseille !
➡️ Read more here